{"pmid": "11205419", "sentences": {"sent_1": {"Section": "METHODS", "text": "Cognitive performance and serotonergic function in users of ecstasy .", "entities": {"entity_1": {"text": "Cognitive performance", "class": "Outcome", "negation": 0, "UMLS": "", "start": 0}, "entity_2": {"text": "serotonergic function", "class": "Outcome", "negation": 0, "UMLS": "", "start": 3}, "entity_3": {"text": "ecstasy", "class": "Intervention", "negation": 0, "UMLS": "", "start": 8}}, "relations": {}}, "sent_2": {"Section": "METHODS", "text": "RATIONALE ( +/- ) 3,4-Methylenedioxymethamphetamine ( MDMA or ecstasy ) has been shown to cause long term damage to serotonergic cerebral neurons in animals .", "entities": {}, "relations": {}}, "sent_3": {"Section": "METHODS", "text": "The neurotoxic effects in humans are less clear and little is known about the functional consequences , although some studies suggest memory impairment .", "entities": {}, "relations": {}}, "sent_4": {"Section": "METHODS", "text": "Given the widespread use of MDMA , our lack of knowledge raises concerns .", "entities": {}, "relations": {}}, "sent_5": {"Section": "METHODS", "text": "OBJECTIVE We investigated , in humans , the relation between past use of ecstasy and cognitive performance as well as serotonergic function .", "entities": {"entity_4": {"text": "relation", "class": "Outcome", "negation": 0, "UMLS": "", "start": 8}, "entity_5": {"text": "past use of ecstasy", "class": "Intervention", "negation": 0, "UMLS": "", "start": 10}, "entity_6": {"text": "cognitive performance", "class": "Outcome", "negation": 0, "UMLS": "", "start": 15}, "entity_7": {"text": "serotonergic function", "class": "Outcome", "negation": 0, "UMLS": "", "start": 20}}, "relations": {}}, "sent_6": {"Section": "METHODS", "text": "METHODS Two groups of 21 males with moderate and heavy recreational use of MDMA , respectively , and a control group of 20 males without use of MDMA were compared", "entities": {"entity_8": {"text": "males", "class": "Participant", "negation": 0, "UMLS": "", "start": 5}, "entity_9": {"text": "moderate and heavy recreational use of MDMA", "class": "Intervention", "negation": 0, "UMLS": "", "start": 7}, "entity_10": {"text": "males", "class": "Participant", "negation": 0, "UMLS": "", "start": 23}, "entity_11": {"text": "without use of MDMA", "class": "Intervention", "negation": 0, "UMLS": "", "start": 24}}, "relations": {}}, "sent_7": {"Section": "METHODS", "text": ".", "entities": {}, "relations": {}}, "sent_8": {"Section": "METHODS", "text": "All were from the same subculture .", "entities": {}, "relations": {}}, "sent_9": {"Section": "METHODS", "text": "Reaction time , direct recall , and recognition were assessed .", "entities": {"entity_12": {"text": "Reaction time", "class": "Outcome", "negation": 0, "UMLS": "", "start": 0}, "entity_13": {"text": "direct recall", "class": "Outcome", "negation": 0, "UMLS": "", "start": 3}, "entity_14": {"text": "recognition", "class": "Outcome", "negation": 0, "UMLS": "", "start": 7}}, "relations": {}}, "sent_10": {"Section": "METHODS", "text": "Serotonergic function was measured by the neuro-endocrine response to a placebo-controlled , crossover challenge with dexfenfluramine .", "entities": {"entity_15": {"text": "Serotonergic function", "class": "Outcome", "negation": 0, "UMLS": "", "start": 0}, "entity_16": {"text": "neuro-endocrine response", "class": "Outcome", "negation": 0, "UMLS": "", "start": 6}, "entity_17": {"text": "dexfenfluramine", "class": "Intervention", "negation": 0, "UMLS": "", "start": 15}}, "relations": {}}, "sent_11": {"Section": "METHODS", "text": "RESULTS Ecstasy users showed a broad pattern of statistically significant , but clinically small , impairment of memory and prolonged reaction times .", "entities": {"entity_18": {"text": "Ecstasy", "class": "Intervention", "negation": 0, "UMLS": "", "start": 1}, "entity_19": {"text": "broad pattern", "class": "Outcome", "negation": 0, "UMLS": "", "start": 5}, "attribute_1": {"text": "clinically small", "class": "modifier", "negation": 0, "UMLS": "", "start": 12}, "entity_20": {"text": "impairment of memory", "class": "Outcome", "negation": 0, "UMLS": "", "start": 15}, "attribute_2": {"text": "prolonged", "class": "modifier", "negation": 0, "UMLS": "", "start": 19}, "entity_21": {"text": "reaction times", "class": "Outcome", "negation": 0, "UMLS": "", "start": 20}}, "relations": {}}, "sent_12": {"Section": "METHODS", "text": "Heavy users were affected stronger than moderate users .", "entities": {"entity_22": {"text": "Heavy users", "class": "Intervention", "negation": 0, "UMLS": "", "start": 0}, "attribute_3": {"text": "affected stronger", "class": "modifier", "negation": 0, "UMLS": "", "start": 3}, "entity_23": {"text": "moderate users", "class": "Intervention", "negation": 0, "UMLS": "", "start": 6}}, "relations": {}}, "sent_13": {"Section": "METHODS", "text": "Release of cortisol but not of prolactin after dexfenfluramine administration was significantly reduced in both groups of ecstasy users compared with the controls .", "entities": {"entity_24": {"text": "Release of cortisol but not of prolactin", "class": "Outcome", "negation": 0, "UMLS": "", "start": 0}, "entity_25": {"text": "dexfenfluramine", "class": "Intervention", "negation": 0, "UMLS": "", "start": 8}, "attribute_4": {"text": "significantly reduced", "class": "modifier", "negation": 0, "UMLS": "", "start": 11}, "entity_26": {"text": "ecstasy", "class": "Intervention", "negation": 0, "UMLS": "", "start": 17}, "entity_27": {"text": "controls", "class": "Intervention", "negation": 0, "UMLS": "", "start": 22}}, "relations": {}}, "sent_14": {"Section": "METHODS", "text": "Analyses of covariance showed that likely confounding variables including recent exposure to ecstasy , psychosocial profiles and use of other drugs did not explain the differences found between the groups", "entities": {}, "relations": {}}, "sent_15": {"Section": "METHODS", "text": ".", "entities": {}, "relations": {}}, "sent_16": {"Section": "METHODS", "text": "CONCLUSIONS These results provide further evidence that use of ecstasy may be associated with impairment of memory and of serotonergic function .", "entities": {"entity_28": {"text": "ecstasy", "class": "Intervention", "negation": 0, "UMLS": "", "start": 9}, "entity_29": {"text": "impairment of memory and of serotonergic function", "class": "Outcome", "negation": 0, "UMLS": "", "start": 14}}, "relations": {}}, "sent_17": {"Section": "METHODS", "text": "These findings are compatible with neurotoxicity of ecstasy as shown in animals .", "entities": {}, "relations": {}}}}